PMID: 2210810Oct 1, 1990Paper

Diurnal cardiovascular patterns in spontaneously hypertensive and Wistar-Kyoto rats

R HenryM P Printz


This study was designed to determine whether diurnal patterns of blood pressure, heart rate, or locomotor activity differed among two substrains of Wistar-Kyoto rats, derived originally from Charles River or Taconic Farms stock, or the spontaneously hypertensive rat. Cardiovascular parameters were continuously monitored over 24 hours. Resting systolic and diastolic blood pressure values were statistically different among the three groups both during the lights-on (rest) and lights-off (active) phases of the cycle with blood pressure of spontaneously hypertensive rats greater than that of Wistar-Kyoto rats from Taconic Farms, which was greater than that of Wistar-Kyoto rats from Charles River. The largest difference in arterial pressure between Wistar-Kyoto/Taconic Farms and Wistar-Kyoto/Charles River was during the lights-on period. Heart rates of all rats decreased during the lights-on period; Wistar-Kyoto/Charles River had the largest decrease (-70 +/- 5 beats/min), Wistar-Kyoto/Taconic Farms had the least (-17 +/- 2 beats/min), and in spontaneously hypertensive rats the decrease was intermediate (-29 +/- 3 beats/min). The pronounced diurnal variation in pressure and heart rate exhibited by Wistar-Kyoto/Charles River was not ...Continue Reading


Dec 1, 1978·Clinical Science and Molecular Medicine. Supplement·M W Millar CraigE B Raftery
Mar 1, 1976·The American Journal of Physiology·H N Sapru, S C Wang
Jan 1, 1985·European Journal of Clinical Pharmacology·A D Struthers, C T Dollery
Jul 1, 1988·Bulletin of Environmental Contamination and Toxicology·H F Loyke
Aug 1, 1986·Clinical and Experimental Pharmacology & Physiology·V EijzenbachC Borst
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·G ManciaA Zanchetti
Apr 1, 1984·The Journal of Clinical Investigation·H P SchedlH D Wilson
Sep 1, 1982·The American Journal of Physiology·G L Wright, G O Rankin
Nov 1, 1982·Hypertension·W H BeierwaltesP J Klemmer
Mar 1, 1963·Japanese Circulation Journal·K OKAMOTO, K AOKI
Jan 1, 1963·Journal of Helminthology·G S NELSON, J MUKUNDI

❮ Previous
Next ❯


Feb 1, 1994·Physiology & Behavior·B J JanssenW J Rietveld
Nov 22, 1997·European Journal of Pharmacology·M ShibasakiI Yanagisawa
Mar 21, 2002·Clinical and Experimental Pharmacology & Physiology·V BaudrieJ L Elghozi
Dec 5, 1997·Journal of Cardiovascular Pharmacology·K TamuraK Hashimoto
Feb 24, 2001·American Journal of Veterinary Research·T MatsunagaY Shibutani
Aug 10, 2000·Journal of Hypertension·V GrossF C Luft
Oct 14, 2004·Journal of Hypertension·Geoffrey A HeadMaarten van den Buuse
Oct 8, 1999·Clinical and Experimental Hypertension : CHE·A A Palmer, M P Printz
Apr 19, 2005·Alcoholism, Clinical and Experimental Research·Mahmoud M El-Mas, Abdel A Abdel-Rahman
Dec 3, 2014·Behavioural Brain Research·Caroline A BrowneIrwin Lucki
Dec 29, 2007·The Journal of Pharmacology and Experimental Therapeutics·Tamara J van SteegElizabeth C M de Lange
Nov 23, 2018·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Sho TanakaMasanori Abe
Oct 7, 1998·Journal of Applied Physiology·M M MoranR E Grindeland
Sep 15, 2017·Chronobiology International·Germán Domínguez-VíasManuel Ramírez-Sánchez
Apr 22, 2017·Frontiers in Physiology·Tonja W EmansC T Paul Krediet
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Adamu AlemayehuMorton P Printz
May 28, 2020·Journal of Human Hypertension·Fernanda S ThomazMarloes Dekker Nitert
Sep 1, 1994·Japanese Journal of Pharmacology·T KatoM Sakanashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.